Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Kokilaben Dhirubhai Ambani Hospital and Positive Bioscience Launch Mumbai's First Personal Genomics Clinic


News provided by

Positive Bioscience

26 Sep, 2014, 16:35 IST

Share this article

Share toX

Share this article

Share toX

MUMBAI, September 26, 2014 /PRNewswire/ --

Kokilaben Dhirubhai Ambani Hospital (KDAH), in association with Positive Bioscience, today launched Mumbai's first Personal Genomics Clinic that will offer personal genome testing.

The personal genomics test is the most advanced, most comprehensive, one-time test that can help healthy individuals identify their health risks and empower them to become active participants in their own heath care. Positive Bioscience is currently the only company in India to offer such an advanced and sophisticated genetic test.

With a coverage of over 1000 diseases including cancer, heart disease, neurological conditions, diabetes etc. the Personal Genomics Clinic will set unprecedented standards in medical technology and preventive medicine in India.

With this launch of Mumbai's first Personal Genomics Clinic, KDAH now joins the elite group of hospitals in the world including Mayo Clinic, Cleveland Clinic and Stanford, that incorporate personal genomics into medical practice.

Personal Genome Test reports will be made available during a face-to-face, client-centered genetic counseling appointment at KDAH that will last between 30 to 60 minutes with an aim to facilitate in-depth understanding of the report and its implications towards developing an individualised preventive plan for 'at-risk' diseases. This is being spearheaded by a genetic counselor trained at Johns Hopkins University, USA, with expertise in both medical genetics and psychological counseling.

The Personal Genomics Clinic offers the following three tests for healthy individuals:

                        Top 25 Diseases              Top 1000 Diseases
     Top 10 Cancers     Top 10 Cancers +             Top 25 Diseases +
                                            Hundreds of diseases including
                                            cancer, neurological, cardiovascular
                     Coronary Artery        and lifestyle-related diseases
    Breast Cancer    Disease                adding up to over 1000 diseases
    Lung Cancer      Pulmonary Embolism
    Leukemia         Deep Vein Thrombosis
    Lymphoma         Hypertension
    Sarcoma          Parkinson's Disease
    Ovarian Cancer   Alzheimer's Disease
    Cervical Cancer  Stroke
    Stomach Cancer   Epilepsy
    Prostate Cancer  Schizophrenia
    Colorectal
    Cancer           Asthma
                     Diabetes Type I& II
                     Arthritis
                     Cirrhosis
                     Osteoporosis
                     Chronic Obstructive
                     Pulmonary Disease
    Rs. 30,000       Rs. 40,000             Rs. 100,000

For one week only, starting September 29, 2014, all packages will be offered at a 10% discount to support the cause of preventive medicine for diseases that are becoming increasingly common in urban areas like Mumbai. We expect about 200 to 300 people to take advantage of this test during the first week. Angelina Jolie led the way in using technology to beat cancer and now Mumbai can too.

Speaking on this launch, Tina Ambani, Chairperson of Kokilaben Dhirubhai Ambani Hospital said, "We feel proud to launch this cutting-edge technology for personal genomics at our hospital as an initiative of preventive healthcare. I am looking forward to map my own personal genomics and use it as roadmap to monitor my future health needs."

Dr. Santosh Shetty, Executive Director & COO, added, "India lags behind the western world when it comes to disease prevention. One of the important criterions in the launch of this clinic is to bridge this existing gap. It is now well established that Kokilaben Hospital has always ensured in bridging gaps in the area of healthcare in Mumbai, be it in technology or clinical services."

Samarth Jain, CEO of Positive Bioscience says, "Advancements in Genomics are making it possible to shift the focus of medicine from treatment to prevention by personalised strategies. I am really excited with this one-stop Genomics Test Clinic at Kokilaben Dhirubhai Ambani Hospital, where Mumbai residents can now have access to advanced scientific technology, world-class facilities and leading doctors all under one roof, and be proactive partners in their own heath care."

Dr. Santosh Shetty and  Samarth Jain feel positive that this collaboration will help increase life expectancy, provide risk assessment for disease, and will revolutionise heathcare by launching personalised medicine tailored to every individual's unique DNA.

About Positive Bioscience
Positive Bioscience specialises in Cancer Genomics, Personal Genomics and Genomics Research. They offer interpretational analysis of DNA based diagnostic tests for Cancer patients and healthy individuals. This analysis help clinicians personalise the clinical management of cancer and other health conditions.

For more information, visit www.positivebioscience.com

Media Contact: Farooque Shaikh, [email protected], +91-9594777764, Client Operation Lead, Practice Strategic Communications India Pvt Ltd

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.